Effect of Functional Inspiratory Muscle Training in Patients with Multiple Sclerosis

NCT06672770 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2024-11-04

No results posted yet for this study

Summary

This study aims to investigate the effects of functional inspiratory muscle training, basic inspiratory muscle training and physical activity in addition to respiratory exercises on respiratory muscle strength, respiratory function, cognition, walking, balance, functional exercise capacity, physical activity, quality of life and core muscles in volunteer Multiple Sclerosis (MS) patients. This study is planned as a prospective, randomized and experimental study.

Conditions

  • Core Muscles
  • Functional Inspiratory Muscle Training
  • Multiple Sclerosis
  • Respiratory Muscles

Interventions

OTHER

Functional Inspiratory Muscle Training

The functional inspiratory muscle training group will perform basic inspiratory muscle training in the first four weeks of the study and the following exercises with the Powerbreath device in muscle training in the following four weeks: 1. Diaphragmatic breathing exercises 2. Warm-up exercises 3. Trunk strength and lumbopelvic stability exercises 4. Dynamic trunk exercises 5. Postural control exercises 6. Cool-down exercises

OTHER

Basic Inspiratory Muscle Training

The basic inspiratory muscle training group will do muscle training with the POWERbreathe device for eight weeks.

Sponsors & Collaborators

  • Selcuk University

    lead OTHER

Principal Investigators

  • İsmail ÖZSOY, Assoc. Prof. Dr. · Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye

  • Selen GUR OZMEN, Assoc. Prof. Dr. · Bahcesehir University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Istanbul, Türkiye

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-10-31
Completion
2025-12-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06672770 on ClinicalTrials.gov